Share on StockTwits
 

Stock analysts at Summer Street increased their price objective on shares of CONMED Corp. (NASDAQ:CNMD) to $53.00 in a report issued on Friday, Stock Ratings Network reports. Summer Street’s price target would suggest a potential upside of 10.72% from the company’s current price.

A number of other firms have also recently commented on CNMD. Analysts at Ladenburg Thalmann downgraded shares of CONMED Corp. from a “buy” rating to a “neutral” rating in a research note on Friday. They now have a $51.75 price target on the stock, up previously from $42.00. Separately, analysts at Needham & Company raised their price target on shares of CONMED Corp. from $45.00 to $48.00 in a research note on Tuesday. They now have a “buy” rating on the stock. Finally, analysts at Needham & Company raised their price target on shares of CONMED Corp. from $40.00 to $45.00 in a research note on Monday, December 16th. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $45.95.

CONMED Corp. (NASDAQ:CNMD) traded up 0.27% during mid-day trading on Friday, hitting $48.00. 59,278 shares of the company’s stock traded hands. CONMED Corp. has a 52 week low of $29.95 and a 52 week high of $47.97. The stock has a 50-day moving average of $43.05 and a 200-day moving average of $37.36. The company has a market cap of $1.325 billion and a price-to-earnings ratio of 37.08.

CONMED Corp. (NASDAQ:CNMD) last released its earnings data on Thursday, February 13th. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.04. The company had revenue of $203.40 million for the quarter, compared to the consensus estimate of $197.24 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 1.1% on a year-over-year basis. Analysts expect that CONMED Corp. will post $1.94 EPS for the current fiscal year.

CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.